Thor Medical ASA (OSL:TRMED)
kr 1.018 0.014 (1.39%) Market Cap: 239.09 Mil Enterprise Value: 210.39 Mil PE Ratio: 0 PB Ratio: 0.93 GF Score: 39/100

Q3 2019 Nordic Nanovector ASA Earnings Call Transcript

Nov 19, 2019 / 07:30AM GMT
Release Date Price: kr20.1 (-1.72%)
Eduardo Bravo
Nordic Nanovector ASA - CEO

Okay. Okay. So thank you very much, and welcome, everyone. Thank you for joining us this morning for the Q3 results presentation for Nordic Nanovector. I think that most of you know me, but just in case and for those on the web, I'm Eduardo Bravo, I'm the CEO of Nordic Nanovector.

And I'm going to be taking you through the presentation on the Q3 results. And then, I will be joined by Marco and Tone for any questions. Lisa, unfortunately, is ill today. So she's listening from home. So we wish her that she will become better. She's threatened us to do some difficult questions on the web, so if you hear any difficult questions, they may be coming from Lisa herself.

But it's a pleasure to be here, as always. Let me -- first of all, as always, I'm going to be making forward-looking statements. Again, probably this is already well-known for most of you, but again, it's always good to start with why Nordic Nanovector and what do we do.

So remember, we have a fully owned asset. And again, this is still very important, a product that we're

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot